$22.44
0.321.45%
At close: Jun 5, 5:00 PM EST
$22.80
0.361.60%
After Hours: May 29, 5:46 PM EST
Sanara MedTech Inc Stock Guidance
SMTINASDAQ
Sanara MedTech (SMTI) last issued guidance on May 11, 2026 for Q2 2026. The company guided revenue in the range of $28.50M - $29.50M for the period.
Compared to prior guidance, Sanara MedTech lowered its revenue forecast from a prior range of $116.00M - $121.00M.
Sanara MedTech has issued 12 guidance updates between February 22, 2023 and May 11, 2026. During this period, the company raised its outlook 5 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
Latest Guidance Date
May 11, 2026
Guidance Period
Q2 2026
Revenue Guidance Range
$28.50M - $29.50M
Sanara MedTech Guidance History
Review all historical guidance issued by Sanara MedTech, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Sanara MedTech (SMTI)?
The most recent guidance for Sanara MedTech (SMTI) was reported on May 11, 2026 for Q2 2026. Sanara MedTech forecasted revenue between $28.50M and $29.50M for the period.
What revenue range did Sanara MedTech (SMTI) guide for?
Sanara MedTech (SMTI) guided revenue in the range of $28.50M to $29.50M for Q2 2026.
Did Sanara MedTech (SMTI) raise or lower guidance?
Sanara MedTech (SMTI) lowered its revenue guidance from a prior range of $116.00M - $121.00M to $28.50M - $29.50M for Q2 2026.
When did Sanara MedTech (SMTI) last issue guidance?
Sanara MedTech (SMTI) last issued guidance on May 11, 2026 for Q2 2026.
